Skip to main content
Premium Trial:

Request an Annual Quote

Whether, and How, to Give DNA Data Back

Geneticists are debating on Twitter whether study participants should have access to their genetic information, Nature News reports.

Cornell University geneticist Charles Danko turned to his Twitter followers for help to convince his institutional review board that they should have such access. Columbia University's Yaniv Erlich responded that millions of people have access to their raw genetic data through services like 23andMe with no adverse events reported.

This discussion, Nature News notes, has been raging for some time, and has mostly centered on the difficulty of accurately predicting disease risk from genetic data.

"The objection to data sharing that I see come up often is that incidental findings from a patient's data set may tell them something about their susceptibility for disease. In some cases, participants may not want to know," Danko tells Nature News. "However, I am not convinced that the risk outweighs a subject's right to access their own data."

The Genomes 2 People research program, which is directed by Harvard Medical School's Robert Green, also gives Danko some advice, should he return such data to participants, suggesting that the presentation of results be customized for each test type.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.